Q4 2013 13F Holders as of 12/31/2013
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
44.8M
-
Number of holders
-
317
-
Total 13F shares, excl. options
-
55M
-
Shares change
-
-310K
-
Total reported value, excl. options
-
$6.21B
-
Value change
-
-$33.8M
-
Put/Call ratio
-
1.25
-
Number of buys
-
3
-
Number of sells
-
-7
-
Price
-
$113.08
Significant Holders of UNITED THERAPEUTICS Corp - Common Stock (UTHR) as of Q4 2013
339 filings reported holding UTHR - UNITED THERAPEUTICS Corp - Common Stock as of Q4 2013.
UNITED THERAPEUTICS Corp - Common Stock (UTHR) has 317 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 55M shares
.
Largest 10 shareholders include FMR LLC (5.26M shares), VANGUARD GROUP INC (2.89M shares), LSV ASSET MANAGEMENT (2.47M shares), AJO, LP (2.26M shares), ACADIAN ASSET MANAGEMENT LLC (2.01M shares), EAGLE ASSET MANAGEMENT INC (1.99M shares), BlackRock Fund Advisors (1.99M shares), HERNDON CAPITAL MANAGEMENT (1.89M shares), BlackRock Institutional Trust Company, N.A. (1.77M shares), and BlackRock Advisors LLC (1.59M shares).
This table shows the top 317 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.